Table 3 Top enriched tissue-based gene sets in complex traits
Phenotype | Tissue (method) | log10BF | Select top driving genes (# of signals) | ||
|---|---|---|---|---|---|
Alzheimer’s disease | Adrenal gland | (SE) | 45.6 | APOE, APOC1 | (2) |
Neuroticism | Brain | (SE) | 26.3 | LINGO1, KCNC2 | (2) |
Adult height | Nerve tibial | (DE) | 25.2b | PTCH1, SFRP4, FLNB | (59) |
Crohn’s disease | Cluster 1a | (DE) | 15.4 | SMAD3, ZMIZ1, NUPR1 | (6) |
Inflammatory bowel disease | Cluster 1a | (DE) | 15.8 | SMAD3, ZMIZ1, NUPR1 | (10) |
Ulcerative colitis | Heart | (HE) | 7.0 | PLA2G2A, TCAP, ALDOA | (4) |
Age at natural menopause | Brain | (DE) | 1053.2 | BRSK1, PPP1R1B, NPTXR | (6) |
Coronary artery disease | Brain | (DE) | 8.5 | PSRC1, ZEB2, PTPN11 | (3) |
Fasting glucose | Pancreas | (SE) | 2396.8 | G6PC2, PDX1, SLC30A8 | (5) |
Fasting insulin | Testis | (SE) | 866.7 | ABHD1, PRR30, C2orf16 | (3) |
Heart rate | Heart | (HE) | 4.1 | MYH6, PLN | (5) |
High-density lipoprotein | Liver | (HE) | 20.2 | APOA1, APOE, MT1G, FTH1 | (10) |
Low-density lipoprotein | Liver | (SE) | 33.4 | ABCG5, LPA, ANGPTL3, HP | (13) |
Total cholesterol | Liver | (DE) | 56.0 | APOA1, APOE, HP | (9) |
Triglycerides | Liver | (HE) | 93.2 | APOA1, APOE, FTH1 | (7) |
Serum urate | Kidney | (SE) | 210.8b | SLC17A1, SLC22A11, PDZK1 | (7) |
Hemoglobin (HB) | Whole blood | (DE) | 2078.1 | HIST1H1E, HIST1H1C | (4) |
Mean cell HB | Whole blood | (DE) | 1363.0 | NPRL3, FBXO7, UBXN6 | (11) |
Mean cell volume | Whole blood | (DE) | 1019.6b | UBXN6, RBM38, NPRL3 | (11) |
Packed cell volume | Heart | (HE) | 945.4 | RPL19, TCAP | (2) |
Red blood cell count | Breast | (SE) | 141.7 | OBP2B, STAC2 | (2) |